BRIEF-Achieve Life Sciences Announces FDA Acceptance Of Cytisinicline New Drug Application For Treatment Of Nicotine Dependence For Smoking Cessation
Reuters
Sep 03
BRIEF-Achieve Life Sciences Announces FDA Acceptance Of Cytisinicline New Drug Application For Treatment Of Nicotine Dependence For Smoking Cessation
Sept 3 (Reuters) - Achieve Life Sciences Inc ACHV.O:
ACHIEVE LIFE SCIENCES ANNOUNCES FDA ACCEPTANCE OF CYTISINICLINE NEW DRUG APPLICATION FOR TREATMENT OF NICOTINE DEPENDENCE FOR SMOKING CESSATION
ACHIEVE LIFE SCIENCES INC - PDUFA TARGETED DATE SET FOR JUNE 20, 2026
Source text: ID:nGNX4wbw1B
Further company coverage: ACHV.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.